bismuth therapy gastrointestinal diseases pubmed ncbi abstract bismuth therapy shown efficacy major gastrointestinal disorders peptic ulcer disease diarrhea peptic ulcer disease effective num receptor antagonists costs considerably offers lower rate relapse helicobacter pylori implicated bismuth acts antimicrobial agent suppressing organism eliminating recent studies bismuth compounds conventional antibiotics producing elimination organism histological improvement amelioration symptoms periods longer year bismuth subsalicylate shown modest efficacy treating traveler's diarrhea acute chronic diarrhea children effective prophylactically traveler's diarrhea epidemic neurological toxicity reported france num prolonged bismuth treatment bismuth subgallate subnitrate toxicity rare bismuth subsalicylate colloidal bismuth subcitrate recent studies demonstrated intestinal absorption bismuth num ingested dose sequestration heavy metal multiple tissue sites occurring conventional dosing num week period findings inspired recommendations treatment periods bismuth-containing compound longer num weeks num week bismuth-free intervals 
